Product
IVDxTx platform is a medical device for monitoring Circulating Tumor Cells (CTCs), Disseminating Tumor Cells (DTCs) and other blood borne diseases. By non-invasively scanning up to one (1) liter of a patient's blood the diagnostic and prognostic potential is much more robust than current technology.
Founders
-
Frank SzczepanskiCEO of IVDiagnostics. Past startups include Stratus Computer, BEA Systems, Ellipsus, Drutt. Personally generated over $1 billion in revenue.
-
Mark HuberDirector of Channels for IVDiagnostics. Founder of the Startup Accelerator, on the Board of the School Factory and the Executive Network Group-Greater Chicago.
-
Joerg SchreiberCEO at Physical Logic Group
-
Ed Wei HeEntrepreneur
-
H. Rossiter Horn, RPhCOO at STABLEBODY TECHNOLOGIES, LLC
-
DARLENE L KITTREDGE,CPADarlene serves as VP Financial Affairs and Coporate Tresurer for IVDiagnostics.
Previous Investors
-
Ken HarringtonManaging Director Skandalaris Center for Entrepreneurial Studies Washington University in St. Louis
-
Arch AngelsUnconfirmed
Advisors
-
Charlie McGillExecutive Director at Entech Innovation Center
-
H. Rossiter Horn, RPhCOO at STABLEBODY TECHNOLOGIES, LLC
-
Roman DziarskiScientific Advisor; Professor of Microbiology and Immunology at IU Medical School.
-
Waclaw SzybalskiProfessor Emeritus of Oncology, McArdle Laboratory for Cancer Research. Scientific Advisor and Nobel Prize nominee.
-
N Joseph EspatDr. Espat serves on IVDiagnostics Medical Advisory Board. He is Co-chair of Surgical Oncology at RWMC in Rhode Island.
-
Tom GalouzisDr. Galouzis is a general surgeon at St. Anthony's - Franciscan Alliance. He served as PI for recent pre-clinical study on cancer patients.
Employees
-
Hui ChenUnconfirmed
